Skip to content

Before You Go · Medication import compliance

Can I Bring Adderall to China?

Last verified: 29 Sep 2026

Travel/import compliance information only — not medical advice. This page does not tell you to start, stop, change, replace, or substitute any medication.

01 Quick answer

Quick verdict: restricted — use the controlled-medicine path

Bottom lineRestricted ingredientsMedical documentsQuantity limitCustoms review
  • The U.S. State Department states that China restricts importation of amphetamine medications including Adderall and advises extreme caution.
  • Inference (ingredient mapping): Adderall’s FDA active ingredients include amphetamine and dextroamphetamine salts. China’s 2025 Category I psychotropic list explicitly includes Amfetamine and Dexamfetamine, and catalogue notes cover relevant salts unless otherwise specified.
  • Chinese traveler/customs guidance provides a documented pathway for medically needed controlled medicines under documentation and single-prescription quantity conditions, with final Customs review.
  • Do not rely on a simplistic “allowed / banned” brand-name answer. Verify current requirements before departure.

02 Naming

Why “Adderall” is not the term Chinese rules use

Chinese narcotic and psychotropic catalogues are organized by substance names, not U.S. brand names. Searching Chinese rules for “Adderall” alone can miss the controlling ingredient listings. The defensible reading starts from the FDA label ingredients, then maps those ingredients to the Chinese catalogue.

03 Ingredients

Adderall active ingredients

Current FDA / DailyMed Adderall labeling lists these active ingredients:

  • dextroamphetamine saccharate
  • amphetamine aspartate / amphetamine aspartate monohydrate
  • dextroamphetamine sulfate
  • amphetamine sulfate

04 Classification

China classification of those ingredients

Fact: The 2025 medicinal psychotropic catalogue Category I list explicitly includes:

  • Amfetamine (苯丙胺)
  • Dexamfetamine (右苯丙胺)
  • Levamfetamine (左苯丙胺)

Fact: Official catalogue notes state:

  • Listed substances include their possible salts and single-substance preparations unless otherwise specified.
  • Listed substances include their possible stereoisomers unless otherwise specified.

Inference: Because Adderall is a mixed-salts amphetamine product, its ingredients map to those Category I listings and salt notes. That is an ingredient-level mapping, not a Chinese catalogue line that says the English brand “Adderall.”

05 Traveler rule

What the traveler / Customs rule requires

For medicines containing narcotic or psychotropic substances needed for medical treatment, Chinese government English FAQ guidance states that narcotic drugs and Category I psychotropic medicines may be carried up to the maximum quantity allowed on a single prescription when diagnosis documentation and identity proof are presented. Travelers are advised to bring supporting documents and proactively declare. Clearance remains subject to Customs on-site review.

06 Documents

Documents to prepare

  • Prescription showing the medicine and quantity.
  • Diagnosis / medical documentation referenced for controlled medicines.
  • Identity proof (passport).
  • Original labelled packaging when possible.

07 Quantity

Quantity and declaration

Official traveler guidance for Category I psychotropic medicines ties quantity to the maximum permitted on a single prescription when the documented medical-treatment pathway applies. Category II rules differ and are not the Adderall ingredient mapping described above. Declare as advised; Customs review is final.

08 Before travel

What to do before departure

  1. Confirm the active ingredients on your Adderall / Adderall XR packaging against the FDA label.
  2. Re-read the State Department China advisory on prescription medications.
  3. Contact the Chinese embassy/consulate with ingredient names, quantity, and documents you will carry.
  4. Ask your airline about controlled-medicine carriage policies.
  5. Pack original packaging and documentation for Customs declaration and review.

Official sources

Last verified: 29 Sep 2026.